says today one day a small cap will break the feurstein-ratain rule. it will be aezs. yakult is running the mm trial and they have a 7.5 billion U.S. market cap. aez-108 will partner with a big pharma.the reason they diluted at a low price was to bide them time and not be at big pharma's mercy because they were low on cash.engel is a smart person but belongs in a lab.if he is replaced aezs goes up at least a buck. kerx was beat down before the good zenerex news just like aezs has been the past few days. just a feeling that the next few weeks will be very profitable for those invested in aezs. also those who bought in the low 2's are up a nice amount.